Log in
Login
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Equities  >  Nasdaq  >  Verisk Analytics, Inc.    VRSK

Delayed Quote. Delayed  - 05/02 09:59:57 pm
77.78 USD   +0.26%
04/27 VERISK ANALYTIC : sells health care services business for $820M
04/27 VERISK ANALYTIC : Unloads Healthcare Services Business for $820M
04/26 VERISK ANALYTIC : Signs Definitive Agreement to Sell Its Healthcare ..
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Income Statement Evolution
Annual Income Statement Data
Actuals in M $ Estimates in M $
Fiscal Period December 201320142015201620172018
Sales1 5961 7472 0682 2992 4602 599
Operating income (EBITDA)7458039961 0911 1791 260
Operating profit (EBIT)679717890853932991
Pre-Tax Profit (EBT)539591717716805880
Net income348400508484540594
P/E ratio32,527,025,527,624,821,9
EPS ( $ )2,022,373,012,813,133,55
Dividend per Share ( $ )------
Yield------
Reference price ( $ )65.7264.0576.8877.7877.7877.78
Announcement Date02/25/2014
07:00am
02/24/2015
09:11pm
02/23/2016
09:11pm
---
Finances - Leverage
Actuals in M $ Estimates in M $
Fiscal Period December 201320142015201620172018
Debt-1 398----
Finance------
Operating income (EBITDA)7458039961 0911 1791 260
Leverage
(Debt/EBITDA)
-1,74x----
Capital Expenditure146147166181184188
Book Value Per Share (BVPS)3,27 $1,34 $8,10 $10,5 $12,9 $14,7 $
Cash Flow per Share2,95 $2,89 $3,70 $4,26 $4,65 $5,68 $
Announcement Date02/25/2014
07:00am
02/24/2015
09:11pm
02/23/2016
09:11pm
---
Balance Sheet Analysis
Assessed data source :
© 2016 Thomson Reuters
Advertisement
Financial Ratios

Size 2016e 2017e
Capitalization 13 054 M$ -
Entreprise Value (EV) - 13 054 M$
Valuation 2016e 2017e
P/E ratio (Price / EPS) 27,6x 24,8x
Capitalization / Revenue 5,68x 5,31x
EV / Revenue - -
EV / EBITDA - -
Yield (DPS / Price) - -
Price to book (Price / BVPS) 7,38x 6,01x
Profitability 2016e 2017e
Operating Margin (EBIT / Sales) 37,1% 37,9%
operating Leverage (Delta EBIT / Delta Sales) - 1,32x
Net Margin (Net Profit / Revenue) 21,1% 22,0%
ROA (Net Profit / Asset) 13,0% 13,6%
ROE (Net Profit / Equities) 32,8% 30,4%
Rate of Dividend - -
Balance Sheet Analysis 2016e 2017e
CAPEX / Sales   7,86% 7,49%
Cash Flow / Sales 31,1% 31,7%
Capital Intensity (Assets / Sales) 1,61x 1,61x
Financial Leverage (Net Debt / EBITDA) - -
Price Earning Ratio Help 
The blue ligne is the average P/E ratio (without estimates)
EPS & Dividend